{"id":242543,"date":"2025-11-24T17:43:14","date_gmt":"2025-11-24T17:43:14","guid":{"rendered":"https:\/\/bm.dev.synology.me\/?p=242543"},"modified":"2026-04-11T15:48:20","modified_gmt":"2026-04-11T15:48:20","slug":"dezamagire-in-industria-farmaceutica-daneza-actiunile-novo-nordisk-au-scazut-cu-12-dupa-ce-compania-a-anuntat-rezultate-slabe-ale-unor-studii-privind-tratamentul-alzheimerului-a-fost-un-bil","status":"publish","type":"post","link":"https:\/\/bm.dev.synology.me\/?p=242543","title":{"rendered":"Dezam\u0103gire \u00een industria farmaceutic\u0103 danez\u0103: Ac\u0163iunile Novo Nordisk au sc\u0103zut cu 12% dup\u0103 ce compania a anun\u0163at rezultate slabe ale unor studii privind tratamentul Alzheimerului. \u201eA fost un bilet la loterie\u201d"},"content":{"rendered":"<p>\nO versiune sub form\u0103 de pastil\u0103 a medicamentului Ozempic, produs de Novo Nordisk A\/S, nu a reu\u015fit s\u0103 \u00eencetineasc\u0103 progresia bolii Alzheimer \u00eentr-un set de dou\u0103 studii, noteaz\u0103 Bloomberg.<\/p>\n<p>\nPacien\u0163ii care au luat medicamentul nu au observat o progresie mai lent\u0103 a bolii pe baza unei evalu\u0103ri cognitive, a declarat luni produc\u0103torul danez de medicamente. Ac\u0163iunile companiei s-au pr\u0103bu\u015fit cu p\u00e2n\u0103 la 12,4% la Copenhaga, ating\u00e2nd cel mai sc\u0103zut nivel din iulie 2021.<\/p>\n<p>\nE\u015fecul elimin\u0103 una dintre ultimele speran\u0163e r\u0103mase pentru o redresare pe termen scurt a Novo sub noul director executiv, Mike Doustdar, chiar dac\u0103 produc\u0103torul descrisese studiile privind Alzheimer drept un demers cu \u015fanse mici de reu\u015fit\u0103. Compania se lupt\u0103 s\u0103 \u00ee\u015fi recapete pozi\u0163ia dup\u0103 ce a pierdut locul \u00eent\u00e2i pe pia\u0163a obezit\u0103\u0163ii \u00een favoarea Eli Lilly &amp; Co.<\/p>\n<p>\n\u201eA fost un bilet la loterie care ar fi putut avea o valoare mare\u201d, a spus Per Hansen, economist de investi\u0163ii la Nordnet AB.<\/p>\n<p>\nCapacitatea de a \u00eencetini m\u0103car pu\u0163in aceast\u0103 boal\u0103 care distruge memoria ar fi putut fi transformatoare, potrivit lui Evan Seigermann, analist la BMO Capital Markets. Valoarea Novo s-a \u00eenjum\u0103t\u0103\u0163it anul acesta, pe fondul \u00eengrijor\u0103rilor investitorilor privind competitivitatea sa pe termen lung.<\/p>\n<p>\nBoala Alzheimer, care provoac\u0103 un declin cognitiv devastator, pierderi de memorie \u015fi schimb\u0103ri de personalitate, este un domeniu notoriu de dificil \u00een dezvoltarea de medicamente. Dar poten\u0163ialul c\u00e2\u015ftig este uria\u015f: Un succes ar fi putut aduce p\u00e2n\u0103 la 5 miliarde de dolari \u00een plus anual, potrivit anali\u015ftilor Morgan Stanley.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>O versiune sub form\u0103 de pastil\u0103 a medicamentului Ozempic, produs de Novo Nordisk A\/S, nu a reu\u015fit s\u0103 \u00eencetineasc\u0103 progresia bolii Alzheimer \u00eentr-un set de dou\u0103 studii, noteaz\u0103 Bloomberg. Pacien\u0163ii care au luat medicamentul nu au observat o progresie mai lent\u0103 a bolii pe baza unei evalu\u0103ri cognitive, a declarat luni produc\u0103torul danez de medicamente. [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[510],"tags":[7172,36542,8088,8967,15494,8327],"class_list":["post-242543","post","type-post","status-publish","format-standard","hentry","category-actualitate","tag-actiuni","tag-alzheimer","tag-farma","tag-loterie","tag-novo-nordisk","tag-scadere"],"_links":{"self":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts\/242543","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=242543"}],"version-history":[{"count":1,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts\/242543\/revisions"}],"predecessor-version":[{"id":242569,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts\/242543\/revisions\/242569"}],"wp:attachment":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=242543"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=242543"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=242543"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}